Table 2.

Susceptibility testing of ciclopirox olamine-loaded conventional and stealth liposomes against C. neoformans clinical strains

Cryptococcus neoformans clinical strains	CPO-LipoC		CPO-LipoS
	MIC	MFC	MIC	MFC
	mg/L		mg/L
URM 5809	2	8	2	8
URM 5810	1	2	1	2
URM 5811	1	1	1	1
URM 5812	1	2	1	2
URM 5813	1	1	1	1
URM 5814	1	2	1	2
URM 5815	1	2	1	2
URM 5816	1	2	1	2
URM 5818	1	8	1	8
URM 5819	2	8	2	8
URM 5820	1	2	1	2
URM 5821	1	8	1	8
URM 5822	2	8	2	8
URM 5823	2	8	2	8
URM 5824	1	1	1	1
URM 5825	1	1	1	1
URM 117	2	2	2	2
URM 123	1	2	1	2
URM 124	1	1	1	1
URM 125	1	2	1	2
URM 126	1	2	1	2
URM 127	1	2	1	2
URM 128	1	2	1	2
URM 129	2	2	2	2
URM 131	2	2	2	2
URM 132	2	4	2	4
URM 144	2	4	2	4
URM 150	1	2	1	2
URM 151	1	2	1	2
URM 155	1	2	1	2
URM 156	2	2	2	2
URM 157	1	2	1	2

CPO-LipoC, ciclopirox olamine-loaded conventional liposomes; CPO-LipoS, ciclopirox olamine-loaded stealth liposomes; MIC, minimum inhibitory concentration; MFC, minimum fungicidal concentration